| The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. |
| Author(s): Mokhles MM1, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC |
| Affiliations(s): 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands. |
| Publication(s): Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23. |
| Document Type(s): Article |
| Countries: Italy, Netherlands, UK |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Drug safety, Neurological disorders
2012 |
|
L:
A: |
English
Retrospective database analysis |
|
 |
| |
| |
| DIA J 2008 |
| Author(s): Dreyer NA, Sheth N, Trontell A, Gliklich RE |
| Affiliations(s): |
| Publication(s): Good practices for handling adverse events detected through patient registries |
| Document Type(s): Abstract |
| Countries: |
C:
Y: |
Drug safety
2008 |
|
L:
A: |
English
RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
| The Monitor Association of Clinical Trial Professionals |
| Author(s): Dreyer NA, Bertagna M, and Gliklich RE |
| Affiliations(s): |
| Publication(s): |
| Document Type(s): Article |
| Countries: |
C:
Y: |
Drug safety
2007 |
|
L:
A: |
English
RWLPR (Real-World Late Phase Research-quintiles |
|
|
| |
| |
 4 of 4
|
